InvestorsHub Logo

mxp

02/16/21 6:55 AM

#10493 RE: konshe #10492

I tend to beleive in that too, after digging more into this ticker. From 2019:

<<Rejuvenate Bio-Sciences Inc. (NUUU)

Rejuvenate Bio-Sciences Inc. is a company that plans to rejuvenate dogs using gene therapy. If they are are successful, they plan to try the same approach in people, and their lead biologist might be one of the first volunteers. It also has a couple of subsidiaries that are picking up steam themselves.

NUUU is one to watch and also be sure to check out this stock that is currently flying under the radar and has a lot of room for growth in the coming months http://bit.ly/2FRn2Wh.

The company prefers to stay out of the public eye to protect its intellectual property but in recent news it has ran a bunch of trials in mice and dogs and hopes to move on to humans soon. At this point not much is known about the dog trial except that the new gene therapy has been tested on four beagles with the help of Tufts Veterinary School in Boston.

A quick look at their recent volume shows 246.51M right before closing on friday and a high of 26.11M at 1 PM of Monday February 4th. What do you guys think about this stock?>>
https://www.facebook.com/stockmarkettimes/photos/a.231607144402136/276488029914047/?type=3&theater

Should I remind you that this company has never had a r/s! Only going north from here!